Geode Capital Management’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-352,814
| Closed | -$476K | – | 5093 |
|
|
2021
Q4 | $476K | Buy |
352,814
+4,381
| +1% | +$5.91K | ﹤0.01% | 4074 |
|
|
2021
Q3 | $1.01M | Buy |
348,433
+62,945
| +22% | +$183K | ﹤0.01% | 3668 |
|
|
2021
Q2 | $996K | Sell |
285,488
-115,589
| -29% | -$403K | ﹤0.01% | 3605 |
|
|
2021
Q1 | $1.37M | Buy |
401,077
+127,824
| +47% | +$437K | ﹤0.01% | 3427 |
|
|
2020
Q4 | $5.25M | Buy |
273,253
+73,965
| +37% | +$1.42M | ﹤0.01% | 2578 |
|
|
2020
Q3 | $2.68M | Buy |
199,288
+2,799
| +1% | +$37.6K | ﹤0.01% | 2721 |
|
|
2020
Q2 | $8.32M | Buy |
196,489
+24,785
| +14% | +$1.05M | ﹤0.01% | 2038 |
|
|
2020
Q1 | $4.74M | Buy |
171,704
+3,718
| +2% | +$103K | ﹤0.01% | 2182 |
|
|
2019
Q4 | $5.45M | Buy |
167,986
+4,342
| +3% | +$141K | ﹤0.01% | 2399 |
|
|
2019
Q3 | $4.26M | Buy |
163,644
+34,576
| +27% | +$900K | ﹤0.01% | 2472 |
|
|
2019
Q2 | $4.74M | Buy |
129,068
+22,036
| +21% | +$808K | ﹤0.01% | 2433 |
|
|
2019
Q1 | $2.37M | Buy |
107,032
+13,190
| +14% | +$292K | ﹤0.01% | 2756 |
|
|
2018
Q4 | $1.32M | Buy |
93,842
+21,168
| +29% | +$298K | ﹤0.01% | 2987 |
|
|
2018
Q3 | $1.41M | Buy |
72,674
+2,400
| +3% | +$46.6K | ﹤0.01% | 3076 |
|
|
2018
Q2 | $1.55M | Buy |
70,274
+8,236
| +13% | +$182K | ﹤0.01% | 2996 |
|
|
2018
Q1 | $1.31M | Buy |
+62,038
| New | +$1.31M | ﹤0.01% | 2990 |
|